跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 93,313 条关于
“EGFR-driven cancers”
全部
93,313
临床试验
76,003
药物
2,397
机构
337
资讯
14,576
4个月前
AstraZeneca Exercises Option for Pinetree's First-in-Class EGFR Degrader in $500M+ Deal
8个月前
EpiBiologics Raises $107M Series B to Advance Novel EGFR-Targeting Bispecific Antibody EPI-326 into Clinical Trials
2个月前
Targeted Therapies Transform Stage 4 Lung Cancer from Death Sentence to Chronic Condition
6个月前
Black Diamond Therapeutics Reports Promising Phase 2 Data for Silevertinib in EGFR-Mutant Cancers
去年
UCLA Researchers Receive $950,000 Grant to Launch Multi-Institutional Trial of Zipalertinib for EGFR-Mutated Cancers
上个月
Iterion Therapeutics Strengthens Board as Tegavivint Expands Across Wnt-Driven Cancers
去年
EnGeneIC Launches Phase I/IIa Trial of Novel EDV Nanocell Therapy for EGFR-Positive Advanced Cancers
去年
Hoth Therapeutics' HT-KIT Shows Promising Preclinical Results in KIT-Driven Cancers
去年
Dana-Farber Launches Center for RAS Therapeutics to Combat Drug Resistance
3个月前
EGFR Inhibitors Market Poised for 7.9% CAGR Growth Through 2036, Driven by Next-Generation TKIs, ADCs, and Bispecific Antibodies
第 1 页,共 1458 页
上一页
下一页